Cti Biopharma reported $38.89M in Equity Capital and Reserves for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Applied Genetic Technologies AGTC:US $ 69.53M 16.28M
Baxter International BAX:US $ 8770M 276M
Bristol Myers Squibb BMY:US $ 37213M 405M
Cti Biopharma CTIC:US $ 38.89M 22.82M
Cytori Therapeutics CYTX:US $ 14.76M 2.81M
Eli Lilly And LLY:US $ 7757M 1312.6M
Geron GERN:US $ 151.55M 24.65M
Mirati Therapeutics MRTX:US $ 1084.03M 44.9M
Northwest Biotherapeutics NWBO:US -301733000 48.11M
Novartis NVS:US $ 56771M 2729M
Novartis NOVN:VX SF 56771M 2729M
Seattle Genetics SGEN:US $ 3164.96M 226.32M
Sunesis Pharmaceuticals SNSS:US $ 103.98M 13.12M
Teva Pharmaceutical Industries TEVA:US $ 10467M 143M
YTE INCY:US $ 3148.66M 212.8M